Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Blockade of CD2 surface expression and expression of chimeric antigen receptors for immunotherapy of T-cell malignancies

Blockade of CD2 surface expression and expression of chimeric antigen receptors for immunotherapy of T-cell malignancies

US Patent 12129485 · Granted Oct 29, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method to specifically stimulate survival and expansion of genetically-modified 2025
Method to specifically stimulate survival and expansion of genetically-modified 2025
T cell receptor-deficient chimeric antigen receptor T-cells and methods of use t2025
T cell receptor-deficient chimeric antigen receptor T-cells and methods of use t2025
Neutralization of human cytokines with membrane-bound anti-cytokine non-signalin2025
Methods for enhancing efficacy of therapeutic immune cells2025
Methods for enhancing efficacy of therapeutic immune cells2025
Methods for enhancing efficacy of therapeutic immune cells2025
Methods for enhancing efficacy of therapeutic immune cells2025
Immune cells comprising truncated NKG2D chimeric receptors2025
Natural killer cells expressing membrane-bound interleukin 15 (mbIL15) and uses 2025
Activating chimeric receptors and uses thereof in natural killer cell immunother2025